SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-012897
Filing Date
2022-07-22
Accepted
2022-07-22 08:32:35
Documents
13
Period of Report
2022-07-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pepg-20220722.htm   iXBRL 8-K 56637
2 EX-10.1 pepg-ex10_1.htm EX-10.1 59269
  Complete submission text file 0000950170-22-012897.txt   243192

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pepg-20220722_lab.xml EX-101.LAB 13342
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pepg-20220722_pre.xml EX-101.PRE 9828
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pepg-20220722.xsd EX-101.SCH 2451
7 EXTRACTED XBRL INSTANCE DOCUMENT pepg-20220722_htm.xml XML 4687
Mailing Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210
Business Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210 703-456-8000
PepGen Inc. (Filer) CIK: 0001835597 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41374 | Film No.: 221098515
SIC: 2834 Pharmaceutical Preparations